Tocqueville Asset Management L.P. decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 19.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 184,205 shares of the real estate investment trust's stock after selling 43,972 shares during the quarter. Tocqueville Asset Management L.P.'s holdings in Healthpeak Properties were worth $3,734,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its holdings in Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. Thrivent Financial for Lutherans bought a new position in Healthpeak Properties in the third quarter worth $1,880,000. Pathstone Holdings LLC bought a new position in Healthpeak Properties in the third quarter worth $1,968,000. Swedbank AB bought a new position in Healthpeak Properties in the third quarter worth $1,832,000. Finally, Associated Banc Corp bought a new position in Healthpeak Properties in the third quarter worth $10,559,000. Hedge funds and other institutional investors own 93.57% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on DOC shares. Wells Fargo & Company decreased their price objective on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, December 10th. Robert W. Baird reduced their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Tuesday, February 11th. Mizuho reduced their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. Scotiabank reduced their price target on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a report on Friday, February 28th. Finally, Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a report on Wednesday, January 15th. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $23.92.
View Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Stock Performance
NYSE DOC traded down $0.34 during trading hours on Friday, hitting $20.02. The company's stock had a trading volume of 7,429,661 shares, compared to its average volume of 4,638,445. The company has a market cap of $14.00 billion, a P/E ratio of 57.19, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company's 50 day simple moving average is $20.24 and its two-hundred day simple moving average is $21.17. Healthpeak Properties, Inc. has a 12 month low of $17.45 and a 12 month high of $23.26.
Healthpeak Properties Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were given a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 6.10%. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is presently 348.57%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
